PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 21: Articles 10001-10500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Evaluating the computer as a data camera in family planning research.
  2. Evaluating the effectiveness of a family planning IE&C program in Bangladesh.
  3. Evaluation of "And the Nile Flows On", family planning-oriented socio-drama: a preliminary draft report.
  4. Evaluation of a new generation of oral contraceptives.
  5. An evaluation of a program to investigate four views of birth control.
  6. Evaluation of A.I.D. family planning programs: Ghana case study.
  7. Evaluation of family planning activities. [Evaluation des activites de PF.]
  8. Evaluation of family planning in India using different approaches: an assessment.
  9. Evaluation of natural family planning programmes in Liberia and Zambia.
  10. An evaluation of Norplant use dynamics in the Indonesian family planning program.
  11. Evaluation of Phase I of South Pacific Regional Family Planning Project (879-0019): assistance to the South Pacific Alliance for Family Health (SPAFH)
  12. Evaluation of risk of thrombosis during use of low-dose ethinylestradiol-desogestrel oral contraceptive.
  13. Evaluation of routine diabetes and lipid screening after age 35 in candidates for or current users of oral contraceptives.
  14. Evaluation of the Chogoria family planning default tracking system.
  15. Evaluation of the Family Planning Training for Paramedical, Auxiliary, and Community Personnel (PAC IIb) Project.
  16. Evaluation of the Operations Research in Family Planning and Maternal-Child Health for Latin America and the Caribbean (INOPAL II) Project.
  17. Evaluation of the training subprojects of the Egypt Population / Family Planning II Project.
  18. Evaluation study of the expansion of use of traditional birth attendants for delivery of maternal and child health, family planning, and nutrition services in five provinces of Burkina Faso (Boulgou, Comoe, Nahouri, Kouritenga and Passore). Baseline survey. [Etude pour tester l'expansion de l'utilisation des accoucheuses villageoises pour les prestations de services de SMI/PF/NUT dans cing provinces du Burkina Faso (Boulgou, Comoe, Nahouri, Kouritenga et Passore). Enquete de base.]
  19. Even as politics improve, challenges facing family planning providers mount.
  20. The events in which community members participate in the family planning program.
  21. Evolution of steroids and their contraceptive and therapeutic use.
  22. The evolution, operation and future of Minnesota SAFPLAN: a coalition for family planning.
  23. An examination of the psychometric properties of the Contraceptive and Prophylactic Behavior Questionnaire (CPBQ)
  24. Exchange rates and the costs of family planning [letter]
  25. Exchange rates and the costs of family planning. The authors reply [letter]
  26. Executive summary. Collection: Family planning situation in Bolivia. [Resumen ejecutivo. Coleccion: Situacion de la planificacion familiar en Bolivia.]
  27. Expanding and improving coverage of family planning services: an Asian and Pacific perspective.
  28. Expanding choice in long term planning for family futures.
  29. Expanding family planning delivery systems using traditional health practitioners: an operations research study in rural Kenya.
  30. Expansion of family planning in Tanzania: strategy for a national CBD program.
  31. Experience of family planning health education in urban China.
  32. Expert Group Meeting on Family Planning, Health and Family Well-Being.
  33. Extended use-effectiveness of contraception.
  34. Factor VII activation and oral contraceptives.
  35. Factors Affecting a Woman's Decision to Have a Tubal Ligation or to Use Norplant: final report. Hopital Aristide le Dantec Clinique Gyneco-Obstetrique, Association for Voluntary Surgical Contraception (AVSC), Senegal. Contract No. CI92.78A, May-August 1993. [Facteurs Affectant la Decision d'une Femme de Subir une Ligature de Trompe ou d'Utiliser le Norplant: rapport final. Hopital Aristide le Dantec Clinique Gyneco-Obstetrique, Association pour la Contraception Chirurgicale Volontaire (ACCV), Republique du Senegal. Contract No.: CI92.78A, mai 1993 - aout 1993.]
  36. Factors affecting contraceptive use in Sub-Saharan Africa.
  37. Factors affecting the use of contraception in Bangladesh: a multivariate analysis.
  38. Factors associated with sexual activity and contraceptive use with female high school students at Ohio University.
  39. Factors influencing attitudes about Norplant contraceptive subdermal implant.
  40. Factors influencing infant/child mortality in Bangladesh: implication for family planning programs and policies.
  41. Factors that determine prevalence of use of contraceptive methods for men.
  42. Facts about contraceptive implants.
  43. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
  44. Faculty of Family Planning [editorial]
  45. Family factors influencing adolescent sexual and contraceptive behavior.
  46. Family planning [editorial]
  47. Family planning [letter]
  48. Family planning -- a priority social and health action programme for Africa and the role of the physician.
  49. Family planning -- experiences and plans. Interview with Purificacao Araujo. [Planeamento familiar -- experiencias e projectos. Em conversa com Purificacao Araujo.]
  50. Family planning -- what is the reality? A study of Gouveia. [Planeamento familiar -- que realidade? Um estudo em Gouveia.]
  51. Family planning / sex education / teenage pregnancy.
  52. Family planning / sex education / teenage pregnancy.
  53. Family planning among native and migrant women, 1989. The case of the cities of La Paz, El Alto, Cochabamba and Santa Cruz. [La planificacion familiar entre las mujeres nativas y migrantes, 1989. El caso de las ciudades de La Paz, El Alto, Cochabamba y Santa Cruz.]
  54. Family planning an excellent investment, says World Bank. NGOs urge Europe to contribute more.
  55. Family planning and AIDS / HIV intervention from a cross-cultural perspective: enhancing the pharmacist's role.
  56. Family planning and desire for additional children after cesarean section.
  57. Family planning and family welfare in Nepal.
  58. Family planning and future management of population growth.
  59. Family planning and Islamic jurisprudence.
  60. Family planning and population: a compendium of international statistics.
  61. Family planning and reproductive health.
  62. Family planning and the missing male factor.
  63. The Family Planning Association of Kenya and Johns Hopkins University / Population Communication Services Client and Provider Information, Education and Communication Project instructional manual for research assistants.
  64. Family planning at your fingertips: adapted from the pages of Contraceptive Technology.
  65. Family planning audience segmentation plan. Ghana Family Planning and Health Project. Preaching to the almost converted.
  66. Family planning by voluntary male sterilization. [Familienplanung durch freiwillige sterilisation des Mannes.]
  67. Family planning campaign brief 1994.
  68. Family planning can contribute to health for all.
  69. A family planning center: role of the nurse. [Un centre de planification familiale: place et role de l'infirmiere.]
  70. Family planning clinics. Attitudes are important [letter]
  71. Family planning clinics. Most give a good service [letter]
  72. Family planning counseling: an evolving process.
  73. Family planning counseling: the international experience. Meeting report, Istanbul, Turkey, April 20-24, 1992.
  74. Family planning counseling: the international experience. Meeting report, Istanbul, Turkey, April 20-24, 1992.
  75. Family planning education helps build self-esteem.
  76. Family planning emergencies [letter]
  77. Family planning encompasses sexuality -- an Asian perspective.
  78. Family planning for all families [editorial]
  79. Family planning for couples in rural areas.
  80. Family planning from the midwife's perspective. [La planification familiale vue par une sage-femme.]
  81. Family planning gets a new boost.
  82. Family planning handbook. Reference handbook for community based distributors in Kenya 1993.
  83. Family planning health and hygiene.
  84. Family planning hygiene project.
  85. Family planning IEC and service delivery in the private sector.
  86. Family planning in a rural population of Crete, Greece --results of a health interview survey.
  87. Family planning in Benin: what future? [La planification familiale au Benin: quel avenir?]
  88. Family planning in China. All coercion?
  89. Family planning in Europe [editorial]
  90. Family planning in India: observations on the 1970, 1980 and 1988 ORG National FP Surveys.
  91. Family planning in Islam.
  92. Family planning in Italy.
  93. Family planning in Latin America's barriadas.
  94. Family planning in Latin America. The battle for the rural areas is not over yet.
  95. Family planning in Maghreb: redefining responsibility.
  96. Family planning in Russia: experience and attitudes of gynecologists.
  97. Family planning in the guidelines of the National Congress. [Planejamento familiar em pauta no Congresso Nacional.]
  98. Family planning in the specific contexts of Bolivia, 1989. Major departments: cities, rest of department. Minor departments: urban, rural. [La planificacion familiar en contextos especificos de Bolivia, 1989. Departamentos mayores: ciudades, resto de departamento. Departamentos menores: urbano, rural.]
  99. Family planning in the teen population.
  100. Family planning in urban Brazil: gaps between policy and practice.
  101. Family planning in Vietnam.
  102. Family planning issues in abortion care.
  103. Family planning issues relating to maternal and infant mortality in the United States.
  104. Family planning knowledge and practice.
  105. Family planning list of questions to be used in needs assessment missions, programme development, etc.
  106. Family planning logistics guidelines.
  107. A family planning miracle.
  108. The family planning movement in Indonesia.
  109. Family planning needs in Uganda: key findings from a baseline survey of selected urban and peri-urban areas, February, 1993.
  110. Family planning needs in Uganda: key findings from a baseline survey of selected urban and peri-urban areas.
  111. The family planning NSW Choices Charter -- a summary.
  112. Family planning operations research in the Philippines.
  113. Family planning practice in central Sudan.
  114. Family Planning Practices among Lebanese, Turkish and Vietnamese Women in Sydney. Reply by authors [letter]
  115. Family planning practices among Lebanese, Turkish and Vietnamese women in Sydney.
  116. Family Planning Practices among Lebanese, Turkish, and Vietnamese Women in Sydney [letter]
  117. Family planning practitioner [editorial]
  118. Family planning program effects in developing countries: conclusions and related considerations.
  119. Family planning programme controversies in India.
  120. Family planning programmes in Asia and the Pacific: implications for the 1990s.
  121. Family planning programmes: abuse of cash incentives [letter]
  122. Family planning programmes: the challenge of rising expectations.
  123. Family planning programs in Anhui: challenges of population redistribution.
  124. Family planning programs in industrial establishments: an operations research study.
  125. Family planning quality of care in Asia. Workshop report, April 3-8, 1993, Center for Development Management, Rajendrapur, Bangladesh.
  126. Family planning saturation project.
  127. Family planning saves lives and P303 billion for the Philippine government.
  128. Family planning services [letter]
  129. Family planning services -- the needs of young people. A report from Mid Staffordshire.
  130. Family planning services -- what's new.
  131. Family planning social marketing for community-based distribution (CBD Phase 1 - baseline)
  132. Family planning use in the context of the AIDS epidemic in Uganda.
  133. Family planning with male involvement -- Mardan. Overall program evaluation of projects and activities funded by Pathfinder International, Pakistan, 1986-1992.
  134. Family planning's benefits include improved child health and nutrition: new data from Bangladesh.
  135. Family planning. [Planification familiale.]
  136. Family planning. [Planification familiale.]
  137. Family planning. Better training for practice nurses.
  138. Family planning. Meeting challenges: promoting choices. The proceedings of the IPPF Family Planning Congress, New Delhi, October 1992.
  139. Family planning. National Epidemiology and Family Health Survey, Honduras, 1991-1992. [Planificacion de familia. Encuesta Nacional de Epidemiologia y Salud Familiar, Honduras 1991 / 1992.]
  140. Family planning: a base to build on for women's reproductive health services.
  141. Family planning: a choice made in total freedom. [La planification familiale: un choix fait en toute liberte.]
  142. Family planning: cultural and religious perspectives.
  143. Family planning: impact on the individual and the family.
  144. Family planning: knowledge, attitudes and practice survey in Zigone, Myanmar.
  145. Family planning: overview on population, environment and development.
  146. Family planning: the Indian experience.
  147. Family size, sex composition of children and contraceptive use: a case study of Kerala.
  148. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
  149. Fatal right ventricular infarction in association with contraceptive pills, without coronary disease [letter]
  150. FDA moves to permit oral contraceptive prescriptions without initial pelvic exam.
  151. Feasibility of distributing contraceptive supplies to encourage family planning practice.
  152. Female adolescent contraceptive decision making and risk taking.
  153. Female adolescents' knowledge of oral contraceptives.
  154. Female age at marriage and family planning behaviour.
  155. Female barrier contraceptive [letter]
  156. Female contraception: changing priorities.
  157. FEMAP education and AIDS prevention programme in a population with high-risk sexual behaviour. (Adaptation of the community health and family planning model)
  158. Fertility and contraceptive use in poor urban areas of developing countries.
  159. Fertility and family planning among the elderly in Taiwan, or integrating the demography of aging into population studies.
  160. Fertility and family planning in Albania.
  161. Fertility awareness -- the Cinderella of family planning.
  162. Fertility following contraceptive use.
  163. The fertility impact of family planning programmes.
  164. The fertility impact of family planning programs.
  165. Fertility, contraception, and infant mortality in the rural area of Piura. [Fecundidad, anticoncepcion y mortalidad infantil en el area rural de Piura.]
  166. Final evaluation of the Clinical Services Improvement Subproject of the Egyptian Family Planning Association under the Population / Family Planning II Project.
  167. Final evaluation of the Family Planning Systems Development Subproject of the Ministry of Health under the Egypt Population / Family Planning II Project.
  168. Final evaluation of the Information, Education, and Communication Subproject of the Egypt Population / Family Planning II Project (No. 263-0144)
  169. Final evaluation of the Pakistan Social Marketing of Contraceptives Project No. 391-0484.
  170. Final evaluation: information, education and communication component of Family Planning Communications and Marketing (FPCM) Project (386-0485), May-June 1993.
  171. Final project report. Turkish Family Planning Media Campaign and Evaluation, Turkey, JHU / PCS Project Nos. NE-TUR-01 and 03.
  172. Final report of an operations research project: "Operations Research to Improve the Sustainability of an Ecuadorian Family Planning Program". Participating agencies: CEMOPLAF, the Population Council / INOPAL II, Family Health International. Subcontract CI91.09A, June 1, 1991 - March 31, 1993.
  173. Final report. "Pricing, Quality of Care, Rumors and Other Possible Causes of Decline in APROFE's New Family Planning Clients: a Diagnostic Study in 14 Ecuadorian Cities". APROFE, Asociacion Pro-Bienestar de la Familia Ecuatoriana, Contract No. CI91.86A, October 1, 1991 - November 30, 1992. Volume 1. [Informe final. "Precios, Calidad de Atencion, Rumores y Otras Posibles Causas de la Caida de Nuevas Usarias de Planificacion Familiar de APROFE: un Estudio Diagnostico en 14 Ciudades Ecuatorianas, APROFE, Asociacion Pro-Bienestar de la Familia Ecuatoriana, Contrato No. CI91.86A, Octubre 1, 1991 -Noviembre 30, 1992. Volumen I.]
  174. Final report. Operations Research Regional Workshop on the Development of the Principles of Quality of Care in Family Planning Programs in Developing Countries, Bandung, Indonesia, February 8-12, 1993.
  175. Final report. Privatization of the Peruvian social security system: a feasibility study for introducing family planning in private health institutions. The Population Council, INOPAL II, MEDIC S.A. / Peru, Centro Medico Ruiz Gonzales, Subcontract No. CI91.58A, September 1, 1991 - May 31, 1993. [Informe final. Privatizacion del sistema peruano de seguridad social: un estudio de factibilidad para introducir la planificacion familiar en instituciones privadas de salud. The Population Council, INOPAL II, MEDIC S.A., Peru, Centro Medico Ruiz Gonzales, Subcontrato No. CI91.58A, 01 de septiembre, 1991 - 31 de mayo de 1993.]
  176. Final report. Project Platypus: FGD Research on Use of, Attitudes toward, and Decision-Making regarding Family Planning. Fixed price contract between the Johns Hopkins University and Total Research Needs, Inc., March 1, 1991 - May 31, 1991, AS-PHI-13.
  177. Final report. Study to test the use of village birth attendants trained as maternal child health - family planning educators and service providers. Ministere de la Sante, de l'Action Sociale et de la Famille, Secretariat General, Direction de la Sante de la Famille, Burkina Faso, Contract No. CI91.13A, March 1991 - January 1993. [Rapport final. Etude pour tester l'utilisation des accoucheuses villageoises formees comme educatrices et prestataires de services de SMI/PF. Ministere de la Sante, de l'Action Sociale et de la Famille (MSASF), Secretariat General, Direction de la Sante de la Famille, Burkina Faso. Contrat No. CI91.13A, Mars 1991 - Janvier 1993.]
  178. Final report. Workshop on Male Participation in Family Planning, Lahore, Pakistan, June 7-9, 1993.
  179. Final report. Workshop on Quality of Services in Family Planning in Pakistan, Faisalabad, Pakistan, November 21-24, 1993.
  180. Final report: Knowledge, Attitude and Practice on Family Planning (Project Bullseye) Wave I.
  181. Final report: Using Creative Media to Deliver Family Planning Messages, Project AF-NGA-11.
  182. Final report: Workshop on Data Analysis in Operations Research for Family Planning, Bhurban, Pakistan, April 18-29, 1993.
  183. Final report: Workshop on Operations Research and the Evaluation of Training and Supervision of Family Planning Service Delivery Personnel, Islamabad, Pakistan, May 17 to 27, 1993.
  184. Financing of family planning programs in Brazil: economic strategies of sustenance.
  185. Findings from two decades of family planning research.
  186. The Fishbein and Ajzen theory of reasoned action applied to contraceptive behavior: model variants and meaningfulness.
  187. Five factors affecting family planning use in Pakistan: an analysis of husbands and wives.
  188. A five-year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors.
  189. Five-year survival of women with breast cancer according to prior use of oral contraceptives.
  190. Foreign aid and family planning [editorial]
  191. Forum: breastfeeding and post-partum contraception.
  192. From abortion to contraception: getting to the Emerald City.
  193. Functional and immunological relevance of the COOH-terminal extension of human chorionic gonadotropin Beta: implications for the WHO birth control vaccine.
  194. The future for injectable contraceptives.
  195. The future of long-term and permanent contraceptive methods. Developments in technology.
  196. Future trends of contraception.
  197. The Gambia: influence of religious leaders on contraceptive acceptance.
  198. Gender of children and contraceptive use.

     

  199. General evaluation of oral contraceptives. [Evaluacion general de los anticonceptivos orales.]
  200. Generalizations about the Indonesian Family Planning Program.
  201. Generating demand for contraceptives in India: a case study of IEC activities in Uttar Pradesh.
  202. Getting family planning programmes right.
  203. Ghana National Family Planning Program Project Number 641-0131. Technical annex: Strengthening contraceptive logistics systems, 1994-2005.
  204. Global view of male involvement in family planning: men and family planning: global signs of change.
  205. GnRH analogues for contraception.
  206. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
  207. Greater contraceptive prevalence: the key to progress. Life comes cheap -- at 2 US$ a head.
  208. Guidelines for clinical procedures in family planning: a reference for trainers. [Lignes directrices pour les procedures cliniques en planification familiale. Une reference pour les formateurs.]
  209. Guidelines for clinical procedures in family planning: a reference for trainers. Second edition. Chapters 3-7, revised 1993.
  210. Guyana Contraceptive Prevalence Survey 1991-92.
  211. Have the AIDS campaigns changed the pattern of contraceptive usage among adolescents?
  212. Health and family planning services cost analysis manual. [Manual de analisis de costos de servicios de salud y de planificacion familiar.]
  213. Health benefits of oral contraception use. [Beneficios para la salud del uso de anticoncepcion oral.]
  214. Health care providers in the Philippines: testing a private sector approach to family planning.
  215. Health care reform and family planning services.
  216. Helping patients choose appropriate contraception.
  217. High contraceptive prevalence in Matlab, Bangladesh: underlying processes and implications.
  218. High-dose progestational contraception: advantages. [Contraception macroprogestative: avantages.]
  219. High-dose progestational contraception: side effects. [La contraception macroprogestative: inconvenients.]
  220. History of contraception in France. [Histoire de la contraception en France.]
  221. The history of steroidal contraceptive development: the estrogens.
  222. HIV / AIDS prevention and control and population / family planning: the potential for integration of programs and activities in Sub-Saharan Africa.
  223. HIV and family planning. [HIV ja perhesuunnittelu.]
  224. Hormonal contraception.
  225. Hormonal emergency contraception.
  226. Hormone antagonism for contraception: GnRH antagonists and antiprogestins.
  227. Household distribution of contraceptives (11 provinces)
  228. Household distribution of contraceptives and the rural health promoter: a case study of Boyaca.
  229. Household distribution of contraceptives.
  230. How contraceptives work.
  231. How economic development and family planning programs combined to reduce Indonesian fertility.
  232. How RTIs affect delivery of family planning services.
  233. How to channel public funds to private family planning programs. [Como canalizar fondos publicos a programas privados de planificacion familiar.]
  234. How to meet contraceptive demands in the 21st century. Cut the red tape and improve access to services. 8th World Congress on Human Reproduction, Bali.
  235. Human immunodeficiency virus transmission and oral contraceptives [letter]
  236. Human immunodeficiency virus transmission and oral contraceptives. Reply [letter]
  237. Human rights, health and development. Halfdan Mahler on the rationale for family planning.
  238. Husband-wife communication and family planning: impact of a national TV drama.
  239. Husband-wife communication: mediating the relationship of household structure and polygyny to contraceptive knowledge, attitudes, and use. A social network analysis of the 1989 Kenya Demographic and Health Survey.
  240. Hysteroscopic assessment of abnormal uterine bleeding in users of the intrauterine contraceptive device.
  241. Ideally suited. Looking at the prospects of natural family planning in the Philippines today.
  242. Identification of family planning needs by surveys. [L'identification des besoins en PF par les enquetes.]
  243. IEC as marketing of services. Marketing contraception through information, education and communication activities.
  244. IMA to conduct training courses in family planning.
  245. IMAP statement on contraception for women with medical disorders.
  246. IMAP statement on Norplant subdermal contraceptive implant system.
  247. IMAP statement on voluntary surgical contraception (sterilization)
  248. Immunological contraception.
  249. Impact of complementary multi-media campaigns on family planning behavior in Nigeria (preliminary results)
  250. The impact of contraceptive measures on human sexual functioning and ways to deal with such impact.
  251. The impact of contraceptive use among urban traders in Nigeria. Ibadan traders and modernisation.
  252. The impact of education on fertility according to region and contraceptive use.
  253. Impact of family planning on health.
  254. The impact of family planning on women's health.
  255. The impact of integrating family planning with an existing program of immunization and growth monitoring.
  256. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms.
  257. The impact of strengthening clinic services and community education programs on family planning acceptance in rural Madagascar.
  258. Implications of reproductive health for objectives and efficacy of family planning programs.
  259. The importance of family planning in developing countries: relations among family planning, fertility and health. [L'interet de la planification familiale dans les pays en developpement: relations entre PF, fecondite, et sante.]
  260. Improving availability of, and accessibility to, contraception.
  261. Improving contraceptive continuation and access to family planning through community based outreach.
  262. Improving contraceptive prevalence through village volunteers.
  263. Improving family planning acceptance through panchayat based clinics and outreach services.
  264. Improving family planning and health services to urban testing workers through hospital-based factory network.
  265. Improving family planning outreach in three urban areas of Indonesia.
  266. Improving the delivery of oral contraceptives.
  267. Improving the effectiveness of family planning programs by improving evaluation capabilities.
  268. In-country training services in family planning.
  269. Incorporating IEC activities for AIDS into a contraceptive community-based distribution (CBD) project in Kinshasa.
  270. Increased contraceptive use in an impoverished society: the case of Bangladesh.
  271. Increasing contraceptive prevalence in low-performance areas.
  272. Increasing family planning acceptance through development programs in northeast Thailand.
  273. Increasing patients' knowledge of secondary contraception [letter]
  274. Increasing the availability and acceptability of contraceptives through community-based outreach in Bas Zaire Programme d'Education Familiale (PRODEF). Original.
  275. India revolutionises its birth control programme.
  276. India's family planning challenge: from rhetoric to action.
  277. India: family planning project stirs Norplant debate.
  278. India: Gujarat State Crime Prevention Trust family planning project.
  279. The Indian family planning programme: impact and prospects.
  280. Indicators of quality of care in family planning programs.
  281. Indicators of quality of care in international family planning programs: clinic-based services, community based distribution, contraceptive social marketing.
  282. Indicators of quality of care in retail outlets selling contraceptive products.
  283. Indices and indicators of family planning needs. [Les indices and les indicateurs de besoins en PF.]
  284. Indonesia moves toward privatization of family planning services.
  285. Indonesia. Financing family planning services and family planning programme sustainability. A country case study.
  286. Indonesia: an assessment of new and conventional methods of contraception.
  287. The Indonesian Population and Family Planning Program.
  288. The induction of ovulation with pulsatile gonadotrophin-releasing hormone (GnRH) administration in in hyperandrogenic women after down-regulation with buserelin or suppressiion with an oral contraceptive.
  289. Industrial setting and family planning promotion and services.
  290. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
  291. Influence of oral contraceptives on fasting gallbladder volume.
  292. The influence of oral contraceptives on the time-integral of thrombin generation (thrombin potential)
  293. Influence of son preference on the contraceptive use and fertility of Sri Lankan women.
  294. The influence of spouses over each other's contraceptive attitudes in Ghana.
  295. Influence of the menstrual cycle and oral contraceptives on thermoregulatory responses to exercise in young women.
  296. Influence of village level health and birth spacing conducted by religious leaders on contraceptive acceptance and continuation rates.
  297. Information needs on emergency contraception not being met.
  298. Information on advances in sciences and technology. Advances in contraceptive technology. [Informacoes sobre avancos em ciencia e tecnologia. Avancos da tecnologia anticonceptiva.]
  299. Information resources and family planning centers in France. [Etablissements d'information et centres de planification familiale en France.]
  300. Information, education and communication needs in family planning: the case of Pakistan.
  301. Inhibition of ovulation by a triphasic gestodene containing oral contraceptive.
  302. Injectable contraception with depot medroxyprogesterone acetate: current status.
  303. Injectable contraceptives and contraceptive vaginal rings.
  304. INOPAL II: eighth semi-annual report. Operations Research and Technical Assistance in Family Planning and Maternal-Child Health in Latin America and the Caribbean, USAID Contract DPE-3030-Z-00-9019-00, April 1 - September 30, 1993.
  305. Inside Nepal: expanding contraceptive choice.
  306. The institutionalization of postpartum family planning in the social security health system of Peru.
  307. Institutionalizing the use of rapid surveys for family planning decision making. [Summary]
  308. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
  309. An integrated approach to operations research for strengthening family planning programs: a case example in Kenya.
  310. Integrating AIDS components into the region's family planning programs.
  311. Integrating community based family planning education and services with primary health care in two rural areas of Cameroon.
  312. Integrating postpartum health care and family planning: the Chilean experience.
  313. Integration of family planning / welfare and social programmes: experiences of the Republic of Korea.
  314. Inter-sectoral activities in the Indonesian family planning program.
  315. International campaign for a halt to research on anti fertility "vaccines" (immunological contraceptives)
  316. The International Conference on Population and Development -- Prepcom II Meeting: intervention by the representative of the Family Planning Association of India.
  317. International training of trainers programs for natural family planning.
  318. Interrelations among lactation, fertility, and infant mortality in Peruvian women not using contraceptives. [Interrelacion entre lactancia, fecundidad y mortalidad infantil en mujeres peruanas no usuarias de anticonceptivos.]
  319. Interview. Mgr. Henry Harry: "The reticence of men with regard to family planning has been based largely..." [Interview. Mgr Henry Harry: "La reticence des hommes vis a vis de la planification familiale a considerablement baisse..."]
  320. Intra-familial communication about contraception: a survey of Black South African freshman.
  321. Intra-uterine contraception and the risk of endometrial cancer.
  322. Intracervical anchoring: a new approach to intrauterine contraception.
  323. Intrauterine contraceptive device and pelvic inflammatory disease.
  324. Intrauterine contraceptive devices [letter]
  325. Intrauterine contraceptive devices -- a reappraisal.
  326. The introduction of community-based family planning services in rural Mali: the Katibougou Family Health Project.
  327. The introduction of community-based family planning services in rural Mali: the Katibougou Family Health Project.
  328. Introductory trial of the once-a-month injectable contraceptive, Cyclofem, in Indonesia.
  329. Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
  330. Iran rebuilds family planning services.
  331. Iron status in Danish women aged 35-65 years. Relation to menstruation and method of contraception.
  332. Is gender preference an obstacle to the success of family planning programmes in rural Bangladesh?
  333. Is the fitting of an intrauterine contraceptive device a painful experience?
  334. Ischemic colitis in a patient with Crohn's disease taking an oral contraceptive and an ergotamine alkaloid.
  335. Issues for family planning in urban slums of Dhaka, Bangladesh: opinions and perceptions of field-level workers.
  336. KB Mandiri: improving village family planning program.
  337. Kenya manages to slow population growth rate. Economic conditions in Africa make family planning more popular.
  338. Kenya: Chogoria Hospital Family Planning Program.
  339. Kenya: Family Planning Private Sector (FPPS) program.
  340. Kisangani: a test of two strategies for family planning service delivery.
  341. Knowledge and practice of contraception in Dhaka urban slums: a baseline survey.
  342. Knowledge and use of secondary contraception among patients requesting termination of pregnancy.
  343. Knowledge deficits and misconceptions in contraceptive use. [Ignorances et prejuges dans l'utilisation de methodes contraceptives.]
  344. Knowledge of AIDS and other sexually transmitted diseases among women attending a family planning clinic in Nairobi, Kenya.
  345. Knowledge of contraception in girls living in the region of Prague. [Uroven znalosti o antikoncepci u divek v prazskem regionu.]
  346. Knowledge, attitude and practice of family planning among fishermen in Tamil Nadu.
  347. Knowledge, understanding, and attitudes of family planning by Iranian males.
  348. Lack of relationship between hip and spine bone mineral density and oral contraceptive use.
  349. Lactational infertility in family planning.
  350. Language, videos and family planning in the South Pacific.
  351. Late miscarriage and intraamniotic candidiasis in a woman with a retained intrauterine contraceptive device.
  352. Latin America's contributions to contraceptive development.
  353. Legal implications of contraception. [Les implications legales de la contraception.]
  354. Letter concerning] public health message regarding which contraceptives provide protection against sexually transmitted diseases (STDs) and which do not.
  355. Levels, trends and determinants of the KAP-gap or the unmet need for contraception in Egypt.
  356. Lipid metabolism effects with desogestrel-containing oral contraceptives.
  357. Liver damage from low-dose oral contraceptives.
  358. Logistics systems and contraceptive supply status review: Malawi Child Spacing and AIDS Control Programs, January 21 - February 21, 1993.
  359. Long acting methods of contraception.
  360. Low cost delivery of contraceptives in rural areas. Euriyong Gun (Tier I)
  361. Low cost delivery of contraceptives in rural areas: Cheju Island (Tier II)
  362. Low cost delivery of maternal and child health and family planning.
  363. Lp(a) levels and antiestrogen antibodies in women with and without thrombosis in the course of oral contraception.
  364. Macroprogestative contraception: advantages. [Contraception macroprogestative: avantages.]
  365. Macroprogestative contraception: side effects. [La contraception macroprogestative: inconvenients.]
  366. Male college students and family planning use in Zambia.
  367. Male contraception: future directions. [Contraception masculine: orientations pour le futur.]
  368. Male IEC needs in family planning: some evidence from Nyamira district, Kenya.
  369. Male influence on female contraception.
  370. Mali launches its first brand-specific oral contraceptives campaign to stimulate trial and usage of the pill.
  371. Many people will accept family planning -- Sulaiman.
  372. The masculine side of family planning: male government employees' attitudes and use of family planning methods in Ghana.
  373. The mass media and family planning in Kenya.
  374. Maternal health and family planning. A handbook for health and family planning projects.
  375. Maternal, child health and family planning in Delta State.
  376. Mauritius Contraceptive Prevalence Survey 1991. Survey report executive summary.
  377. Mauritius Contraceptive Prevalence Survey, 1991. Final report.
  378. Measuring university student satisfaction with a campus family planning clinic in Costa Rica.
  379. Medical and social barriers to contraceptive provision and use in Kenya.
  380. Medical association participation in national family planning program: the experience of Indonesian Medical Association.
  381. Medical audits in the Family Planning Association of India.
  382. Medical barriers to contraceptive use.
  383. Medical oversight in family planning programs: helping providers continuously improve quality.
  384. Medroxyprogesterone acetate granted contraceptive indication in U.S.
  385. Meeting challenges: promoting choices. A report on the 40th anniversary IPPF Family Planning Congress, New Delhi, India.
  386. Meeting the challenge of unmet need for family planning.
  387. Melatonin and oral contraception. [Melatonin a oralni kontracepce.]
  388. Melatonin: a contraceptive for the nineties.
  389. Men and family planning in Portugal.

     

  390. Men and family planning in Zambia.
  391. Men and family planning. [Hombre y planificacion familiar.]
  392. Men's and women's views on condoms and contraceptives: using qualitative research in the development of intervention tools.
  393. Menometrorrhagia in an oral contraceptive user.
  394. Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate / ethinyl estradiol)
  395. Metabolic effects of oral contraceptives. [Efectos metabolicos de los anticonceptivos orales.]
  396. Metabolic effects of oral contraceptives. Implications for exercise responses of premenopausal women.
  397. Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro.
  398. Methodological problems in the evaluation of drug induced sexual dysfunction for oral contraceptives.
  399. Micro-enterprise projects for women - linkages with family planning.
  400. Midterm evaluation of the Family Planning Assistance Project (492-0396): Philippines.
  401. Midterm evaluation of the Family Planning Service Expansion and Technical Support (SEATS) Project (936-3048)
  402. Midterm evaluation of the Guinea Social Marketing of Contraceptives Project.
  403. Minister Peng stresses the necessity for improving the working style in family planning implementation.
  404. Mishaps occurring during condom use, and the subsequent use of post-coital contraception.
  405. Missed opportunities: postpartum family planning in Kenya.
  406. Mobile family planning drama.
  407. A model for integration of HIV and STD prevention into family planning programs -- case study in Jamaica.
  408. Modelling the demographic impacts of family planning and socio-economic correlates.
  409. Modes of family planning service delivery in the slums of Dhaka, Bangladesh: effects on contraceptive use.
  410. Modified contraceptive distribution project.
  411. Money for family planning.
  412. Monitoring structures, processes and outcomes by a prospective study of intrauterine contraceptive devices (IUDs) fitted in community clinics.
  413. Monogamy, contraception and the cultural and reproductive success hypothesis.
  414. More access to contraception? Russian city surveyed.
  415. Motivation for family planning and a reference program employing satisfied contraceptive users along with midwives, Association Burkinabe des Sages-Femmes, Burkina Faso. Contract No. C190.43A / C191.06A, July 1, 1990 - August 28, 1993. Report. [Motivation pour la planification familiale et programme de reference impliquant des utilisatrices de contraceptifs satisfaites ainsi que des sages-femmes, Association Burkinabe des Sages-Femmes (ABSF), Burkina Faso. Contrat No. C190.43A / C191.06A, juillet 1, 1990 - aout 28, 1993. Rapport.]
  416. A multicenter clinical trial in Nigeria with a low-dose oral contraceptive, Marvelon.
  417. A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives.
  418. Multicenter epidemiologic study, in Spain, of a new generation hormonal oral contraceptive. [Estudio epidemiologico multicentrico, con un contraceptivo hormonal oral de nueva generacion, en Espana.]
  419. A multicenter study of the clinical performance of the Ortho Gyne-T380 Slimline intrauterine device in routine use in general practice and family planning clinics.
  420. The Muslim ummah and family planning movement in Indonesia.
  421. The myth about contraceptives and breast cancer.
  422. Myths about oral contraceptives. Does OC availability result in increased sexual activity among teens?
  423. Natural family planning in the Philippines.
  424. Natural family planning: effective birth control supported by the Catholic Church.
  425. Natural family planning. Abstinence unnatural in primates [letter]
  426. Natural family planning. Advocates and detractors have different sexual philosophies [letter]
  427. Natural family planning. An unfair burden on the female partner [letter]
  428. Natural family planning. Author's reply [letter]
  429. Natural family planning. Both partners need instruction [letter]
  430. Natural family planning. Cheap, effective, and free of side effects [letter]
  431. Natural family planning. Demand is increasing [letter]
  432. Natural family planning. Depends on consumers not providers [letter]
  433. Natural family planning. Deprives poor people of sex [letter]
  434. Natural family planning. Double standards on teats and condoms [letter]
  435. Natural family planning. Natural methods have cross cultural appeal [letter]
  436. Natural family planning. Only as reliable as people [letter]
  437. Natural family planning. Review's enthusiasm based on flawed evidence [letter]
  438. Natural family planning. The family planning method of the future [letter]
  439. Natural family planning. The tide is turning in favour [letter]
  440. Natural family planning. Unplanned pregnancy rates declining [letter]
  441. Negotiating intimacy: intrahousehold dynamics, sexuality and birth control experiences of Indian women in poverty.
  442. Neurotologic presentation of sagittal sinus thromboses associated with oral contraceptive usage.
  443. A new (old) contraceptive choice.
  444. New advances in contraceptive technology in China.
  445. New contraception trends among adolescents. [Nuevas tendencias de contracepcion en adolescentes.]
  446. A new contraceptive method: breast feeding. [Une nouvelle methode contraceptive: l'allaitement maternel.]
  447. A new diagnostic aid for natural family planning.
  448. New family planning center serves 60,000 Nicaraguans.
  449. A new family planning tool to slow population growth.
  450. The new intrauterine contraceptive devices: safe and effective.
  451. New labeling for contraceptives -- STDs.
  452. New labeling to provide information about contraceptives and STDs.
  453. New technology for contraception and prevention of STDs.
  454. Nigeria: the family planning situation analysis study.
  455. NIHFW prepares interesting models on family planning.
  456. No cause for conflict. Religion does not emerge as a major reason for their not using contraceptives.
  457. Non-endoscopic surgical contraception (vaginal tubectomy)
  458. Non-users and unmet need for contraception. First report.
  459. Noncontraceptive benefits of oral contraceptive agents. Patients should know the positive effects.
  460. Noncontraceptive benefits of oral contraceptives.
  461. Norplant and the levonorgestrel IUD in Chinese family planning programmes.
  462. Norplant contraceptive implants.
  463. Norplant contraceptive maker accused of profiteering on drug.
  464. The Norplant contraceptive: an Indonesian experience.
  465. Norplant guidelines for family planning service programs. A problem-solving reference manual.
  466. Norplant's maker draws sharp criticism on pricing of long-acting contraceptive.
  467. Norplant-2 subdermal contraceptive system: experience in Taiwan.
  468. Norplant: a welcome new contraceptive.
  469. Norplant: levonorgestrel-releasing contraceptive implant.
  470. Nsona Mpangu: long term impact of community-based distribution (CBD) on contraceptive prevalence.
  471. Obstacle course: funding and policy stifle contraceptive research.
  472. Once-a-month injectable contraceptives.
  473. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
  474. One-year acceptability study of three contraceptive methods: a Kenyan experience.
  475. Operation research to improve the sustainability of an Ecuadorian family planning program.
  476. An operations research (OR) study to test a family planning motivation and referral program using satisfied contraceptive acceptors and midwives.
  477. Operations research project on family planning services in rural areas. Implemented with the Peru Ministerio de Salud and Care / Peru with the technical and financial assistance of the Population Council (INOPAL II). Fourth technical report, March - August, 1993. [Proyecto de investigacion operativa sobre servicios de planificacion familiar en areas rurales. Ejecutado con el Ministerio de Salud del Peru y Care / Peru con la asistencia tecnica y financiera del Population Council (INOPAL II). Cuarto informe tecnico. Marzo - Agosto 1993.]
  478. Operations research: seeking better ways to deliver family planning services in Bangladesh and Africa.
  479. Opinions of various participants on community participation in health and family planning. [Opiniones de los diversos actores sobre la participacion comunitaria en salud y planificacion familiar.]
  480. Options for birth control.
  481. Options for contraceptive social marketing in Malawi: a SWOT analysis of the SOMARC project.
  482. Options for financing family planning. Increasing private sector participation and user fees. Draft.
  483. OPTIONS II Regional Workshop. Decentralization of Population and Family Planning Programs in Anglophone Africa, Kampala and Mbarara, Uganda, June 13-20, 1993.
  484. OR to introduce Depo-Provera to Ecuadorian family planning programs. INOPAL II operations research proposal.
  485. Oral contraception -- benefits and risks.
  486. Oral contraception and cerebral embolisms. [Orale Kontrazeption und zerebrale Embolien.]
  487. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
  488. Oral contraception in the former Czech and Slovak Federal Republic: attitudes and use.
  489. Oral contraception with Moneva: findings of a cohort study of 6000 women. [Contraception orale par Moneva: resultats d'une etude de cohorte portant sur 6.000 femmes.]
  490. Oral contraception. [La contraception orale.]
  491. Oral contraception: advantages of estrogen reduction. [La contraception estroprogestative: avantages de la diminution des estrogenes.]
  492. Oral contraception: disadvantages of estrogen reduction. [Contraception estroprogestative: inconvenients de la diminution des estrogenes.]
  493. Oral contraception: users' questions. [Contraception orale: questions des utilisatrices.]
  494. Oral contraceptive pill use and fractures in women: a prospective study.
  495. Oral contraceptive risk assessment: a survey of 247 educated women.
  496. Oral contraceptive safety: update on common concerns.
  497. Oral contraceptive use and blood pressure levels among women workers in Sao Paulo, Brazil.
  498. Oral contraceptive use and cigarette smoking in Crohn's disease.
  499. Oral contraceptive use and infectivity of HIV-seropositive women [letter]
  500. Oral contraceptive use and risk of benign breast disease in a French case-control study of young women.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.